The biological actions of interferons (IFNs) 1 require the activation of immediate early genes, which are mediated by the Stat family of transcription factors (1). Type 1 interferons (IFN␣/␤) binding to their cell surface receptors initiate a set of events that leads to tyrosine phosphorylation of Stat1 and Stat2. Tyrosine-phosphorylated Stat1 and Stat2 heterodimerize through their Src homology 2 domains and translocate to the nucleus where they bind to interferon regulatory factor 9 (IRF9) to form the transcription complex ISGF3. ISGF3 binds to an interferon-stimulated response element (ISRE) that is present in many IFN␣/␤-stimulated genes. Alternatively, tyrosine-phosphorylated Stat1 can form homodimers and bind to a ␥ interferon activation sequence (GAS), an enhancer in the promoter of genes that do not require the participation of Stat2 or IRF9.
The biological actions of interferons (IFNs) 1 require the activation of immediate early genes, which are mediated by the Stat family of transcription factors (1) . Type 1 interferons (IFN␣/␤) binding to their cell surface receptors initiate a set of events that leads to tyrosine phosphorylation of Stat1 and Stat2. Tyrosine-phosphorylated Stat1 and Stat2 heterodimerize through their Src homology 2 domains and translocate to the nucleus where they bind to interferon regulatory factor 9 (IRF9) to form the transcription complex ISGF3. ISGF3 binds to an interferon-stimulated response element (ISRE) that is present in many IFN␣/␤-stimulated genes. Alternatively, tyrosine-phosphorylated Stat1 can form homodimers and bind to a ␥ interferon activation sequence (GAS), an enhancer in the promoter of genes that do not require the participation of Stat2 or IRF9.
Binding of ISGF3 to cellular genes containing ISREs is accompanied by changes in the chromatin structure of interferonstimulated genes (ISGs) (2) . Cells incubated with IFN␣ show altered DNase I sensitivity surrounding the TATA box region as well as the ISRE of ISGs, suggesting that gene activation occurs as a result of chromatin remodeling (2) . Consistent with this observation, both Stat1 and Stat2 have been shown to interact with the histone acetylases CBP/p300 and GCN5 resulting in increased association of the acetylated histone H3 with the promoter of the IFN␣/␤-stimulated gene ISG54 (3) (4) (5) (6) .
From these observations one would predict that incubation of cells with HDAC inhibitors would increase IFN-activated gene expression, and this is indeed the case when one examines IFN␥-stimulated expression of the MHC-II (7). However, in contrast to IFN␥, interleukin-3-activated Stat5-dependent genes are inhibited in cells exposed to TSA (8) , suggesting that in certain contexts HDAC activity may be required for Stat-dependent gene activation. Interestingly, other genes in which expression is activated by interleukin-3 in a Stat5-independent manner are unaffected by TSA. To examine the role of HDAC activity in the expression of genes regulated by Stat1 and Stat2, we have assayed for the expression of several RNAs in which genes are controlled by these transcription factors. To our surprise the actions of TSA on IFN␣/␤-stimulated gene expression were relatively selective. Whereas some IFN␣/␤-stimulated genes in which expression is regulated by an ISRE were strongly suppressed by TSA, others showed a more modest inhibition. Furthermore, genes in which activation required a GAS element, such as IRF-1, were not altered by TSA treatment. HDAC activity appears to be required to recruit RNA polymerase II (Pol II), but not Stat1 or Stat2, to the promoter of TSA-sensitive genes. The effects of TSA seem to be mediated either directly or indirectly by IRF9. Interestingly, if Pol II is already bound to the promoter and there is basal expression of the gene in the absence of IFN␣/␤ (i.e. IRF-1), then the suppressive actions of TSA are not observed. These data suggest a novel function for IRF9 in promoting RNA Pol II binding to the promoter of genes with activation requiring the activity of HDACs. These results highlight the importance of both histone acetyltransferases and HDACs in controlling potentially distinct targets with regard to Stat-regulated gene expression.
MATERIALS AND METHODS
Cells and Culture-Human foreskin fibroblasts were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (9) . Human IFN␤ (Avonex) was obtained from Biogen Inc. Tri-* This work was supported by National Institutes of Health Grant CA77366. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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RNA Assays-RNase protection assays were performed as described previously (10, 11) .
Preparation of Cell Extracts-Whole cell extracts were prepared by lysing cells in whole cell extraction buffer (20 mM Hepes, 300 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 20% glycerol, 1% Nonidet P-40, 10 mM ␤-glycerophosphate, 1 mM orthovanadate, 25 mM NaF, 200 M phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol). After centrifugation at 4°C for 10 min, supernatants were collected. Nuclear extracts were prepared by resuspension of the crude nuclei in nuclear extraction buffer (20 mM Hepes, 300 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 20% glycerol, 0.1% Nonidet P-40, 10 mM ␤-glycerophosphate, 1 mM orthovanadate, 25 mM NaF, 200 M phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol) (9) .
Electrophoretic Mobility Shift Assays-Double-stranded oligonucleotides corresponding to the ISRE of the ISG15 promoter and the IFN␥ response region sequence of Fc␥RI promoter were used as probes. They were end-labeled with [␥-32 P]ATP using T4 polynucleotide kinase (10) . Western Blot Analysis-Proteins from whole cell extracts were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The membrane was probed with rabbit polyclonal antibody against Stat1, phospho-Stat1 (PY701) (Cell Signaling Technology), phospho-Stat1 (serine 727), Stat2, or phospho-Stat2 (PY690) (Upstate Biotechnology). Following hybridization, the membrane was washed and developed by chemiluminescence.
Transfections and Luciferase Assay-Cells (293T) were transfected using FuGENE (Roche Applied Science) with 1 g of ISRE or GAS luciferase reporter plasmids. These plasmids contain either three copies of the IRF-1 GAS sequence or five copies of the ISG54 ISRE sequence
FIG. 1. Incubation of cells with trichostatin A selectively inhibits IFN␤-stimulated ISRE-dependent gene expression but not tyrosine phosphorylation of Stats.
A, human fibroblasts were incubated with or without TSA (200 ng/ml) for 30 min before IFN␤ (1,000 units/ml) was added for 2 h. RNA was prepared, and expression of ISG54, ISG56, ISG15, 6 -16, and IRF-1 was analyzed by RNase protection assays. As an internal control ␥-actin was also measured in each sample. The degree of inhibition for each RNA sample in the presence of TSA and IFN␤ relative to those samples incubated with IFN␤ was quantitated and normalized to the amount of actin in each sample. This information is shown on the right side of the figure. B, IFN␤-stimulated tyrosine phosphorylation of Stat1 and Stat2 and serine phosphorylation of Stat1 were analyzed by immunoblots using antibodies that recognize PY701 of Stat1, PS727 of Stat1 (pSer-Stat1), or PY690 of Stat2. The blots were stripped and reprobed with antiserum that recognizes all forms of Stat1 and Stat2. In these samples whole cell extracts were prepared after 30 min of incubation with IFN␤. C, IFN␤-stimulated binding of Stats to an ISRE or GAS element as measured by electrophoretic mobility shift assays using nuclear extracts prepared from fibroblasts incubated in the presence or absence of TSA and IFN␤ as described in B. GRR is the GAS element in the promoter of the Fc␥RI gene. located 5Ј to a minimal herpes thymidine kinase promoter (12, 13) . Wild type Stat2 (FLAG-tagged) or Stat1 (hemagglutinin-tagged) or IRF9 plasmid DNA was included in some transfections (12, 14) . Stop codons at amino acids 107, 217, and 327 were introduced into the IRF9 expression plasmid using the Stratagene (La Jolla, CA) QuikChange sitedirected mutagenesis kit. After overnight incubation at 37°C, cells were left untreated or stimulated with IFN␤ for 5 h. Cell lysates were prepared, and luciferase activity was measured and normalized to total protein in the extracts.
Chromatin Immunoprecipitation (ChIP)-PCR-ChIP assays were performed as described by Sakamoto et al. (9) . The Stat2 and RNA Pol II antisera were purchased from Santa Cruz. Stat1 antibody was generated in rabbits as previously described (15) .
RESULTS AND DISCUSSION
To examine the role of HDACs in type 1 IFN-induced gene expression we used primary immortalized human fibroblasts that were incubated in the presence or absence of TSA and IFN␤ (1000 units/ml) for 2 h. RNA was isolated, and RNase protection assays were performed to probe for the presence of ISG54, ISG56, IRF-1, ISG15, and 6 -16 RNAs. Actin was analyzed in the same samples as an internal control (Fig. 1A) . Incubation of cells with TSA inhibited IFN␤-induced expression of ISG54, ISG15, ISG56, and 6 -16, which all contain an ISRE in their promoters. However, this HDAC inhibitor did not significantly affect induction of IRF-1, which is activated through a GAS element. The relative degree of inhibition of the various ISGs by TSA treatment is shown to the right of the RNase protection assay. TSA inhibition of ISGs that contained an ISRE was somewhat variable with ISG15 and 6 -16 being less inhibited than ISG54 and ISG56.
To determine whether incubation of cells with TSA alters IFN␤-stimulated tyrosine phosphorylation of Stat1 and Stat2 and their ability to bind DNA, we performed both immunoblots with phospho-specific antibodies and electrophoretic mobility shift assays. Cells were incubated with IFN␤ in the presence or absence of TSA for 30 min, and whole cell (Fig. 1B) or nuclear (Fig. 1C) extracts were prepared. IFN␤-stimulated tyrosine phosphorylation of Stat1 and Stat2 as well as serine phosphorylation of Stat1 was analyzed by immunoblots using phosphospecific antibodies. Tyrosine phosphorylation of Stat1 and Stat2 is required for them to dimerize and bind to DNA, whereas serine phosphorylation of certain Stats including Stat1 (but not Stat2) is required for their maximal transactivation function (16, 17) . Incubation of cells with TSA had no effect on either IFN␤-stimulated tyrosine phosphorylation of Stat1 or Stat2 or phosphorylation of serine 727 of Stat1 (Fig.  1B) . These findings were confirmed using electrophoretic mobility shift assays to analyze the binding of ISGF3 (Stat1, Stat2, and IRF9) to an ISRE probe (Fig. 1C, upper panel) or Stat1 homodimers to a GAS element (Fig. 1C, lower panel) .
To determine whether the inhibitory actions of TSA were being exerted through the ISRE of ISG54 as opposed to another regulatory region in the promoter, we performed luciferase reporter assays. Reporter constructs containing either the ISRE of the ISG54 promoter or the GAS element of the IRF-1 promoter were transfected into 293T cells. IFN␤ stimulated both ISRE-and GAS-dependent luciferase activities in cells transfected with these reporters (Fig. 2) . Although incubation of cells with TSA inhibited IFN␤-stimulated ISG54-ISRE luciferase activity more than 80%, IFN␤ induction of the IRF-1-GAS luciferase activity was not altered by treatment of cells with TSA. Similar results were observed when cells were transfected with a luciferase reporter containing the ISRE sequence of the ISG15 promoter (data not shown). These results imply that most if not all of the actions of TSA are directed toward the ISRE and not other elements in the promoters of ISRE-containing genes.
Although IFN␤ activation of Stat1 and Stat2 and their ability to bind DNA was not affected by incubation of cells with TSA, we wanted to determine whether binding of these Stats to the endogenous ISG54 and IRF-1 promoters was altered by this HDAC inhibitor. To address this issue, we performed ChIP assays. Human fibroblasts were incubated with or without IFN␤ for 30 min in the presence or absence of TSA. Cells were fixed with formaldehyde, and chromatin was isolated and immunoprecipitated with Stat1, Stat2, or a RNA polymerase IIspecific antiserum. As a control for nonspecific background, chromatin was also precipitated with antiserum that recognizes ␤-actin. Immunoprecipitated chromatin was then subject to PCR with primers corresponding to the promoters of ISG54 or IRF-1 (Fig. 3) (9, 18) . IFN␤ treatment of fibroblasts induced the binding of both Stat1 and Stat2 to the ISG54 promoter (Fig.  3A, lanes 1, 2, 4 , and 5) and of Stat1 to the IRF-1 promoter (Fig.  3B, lanes 1 and 2) . TSA treatment of cells had no effect on the ability of either Stat to bind to the ISG54 (Fig. 3B, lanes 2, 3, 5 , and 6) or IRF-1 (lanes 2 and 3) genes. In striking contrast, TSA completely inhibited the binding of RNA Pol II to the ISG54 promoter (Fig. 3A, lanes 7-9) . RNA Pol II constitutively associates with the IRF-1 promoter, and this association was modestly increased in cells incubated with IFN␤ (Fig. 3B, lanes  4 -6) . The slightly enhanced binding of RNA Pol II to the IRF-1 promoter in IFN␤-treated cells was variable, as was the reversal of this binding in cells exposed to TSA. However, importantly, TSA did not alter the basal or IFN␣/␤-enhanced binding of RNA Pol II to the IRF-1 gene. We did not observe any binding of RNA Pol II to the ISG54 promoter in untreated cells. These results suggest that HDAC activity is required for recruitment of RNA Pol II to the promoter of genes that contain an ISRE. However, the binding of Stat1 and Stat2 to the ISG54 promoter per se is clearly not directly related to the ability of HDACs to induce RNA Pol II binding to the gene. The mechanism by which HDAC activity affects the binding of RNA Pol II to the promoter in the context of the ISRE is unclear. To determine whether any of the known components of ISGF3 (Stat1, Stat2, or IRF9) might be targets for HDAC, we transfected 293T cells with an ISG54 luciferase reporter (see Fig. 2)   FIG. 2 . Incubation of cells with TSA inhibits an IFN␤-stimulated ISRE-dependent reporter but not an IFN␤-stimulated GASdependent reporter. 293T cells were transfected with either an ISG54 ISRE element (5 copies) or an IRF-1 GAS element (3 copies) upstream of a minimal promoter regulating the expression of firefly luciferase (Luc) (12, 13) . 18 h after transfection, cells were incubated with or without IFN␤ and TSA for 5 h before cell extracts were prepared. Luciferase activity was measured and normalized to total protein in each sample, and the -fold induction in samples treated with IFN␤ was determined.
and cDNA expression vectors that encode Stat1, Stat2, or IRF9 (Fig. 4) . 24 h post-transfection cells were incubated with or without IFN␤ or TSA for 6 h, cell extracts were prepared, and luciferase activity was assayed. Incubation of cells with TSA inhibited IFN␤-stimulated ISRE reporter activity (Fig. 4A, lane  3 versus 4) . Co-expression of either Stat1 or Stat2 (Fig. 4A , upper panel) had no effect on the inhibitory actions of TSA (lanes 7 versus 8 and 11 versus 12), whereas expression of IRF9 completely reversed the inhibitory actions of TSA (Fig. 4B,  upper panel, lanes 7 and 8) .
IRF9 contains a DNA binding domain in its N-terminal 127 amino acids and a domain that associates with tyrosine-phosphorylated Stat1 and Stat2 in the 160 amino acids at its C terminus. These domains are separated by 100 amino acids (19) . To determine which domains in IRF9 are required to reverse the inhibitory actions of TSA, we introduced stop codons in the IRF9 expression plasmid to generate proteins that contain either the N-terminal 107, 217, or 326 amino acids of the full-length protein. The cDNAs were transfected into 293T cells with the ISG54 luciferase reporter as in Fig. 4B , and luciferase activity was determined in cells incubated with or without IFN␤ in the presence or absence of TSA (Fig. 4C) . Expression of the N-terminal 107 amino acids of IRF9 failed to reverse the inhibitory actions of TSA. Interestingly, expression of the linker domain of the protein in the context of the N terminus partially reversed the inhibitory effects of TSA, whereas expression of the first 326 amino acids of the protein fully reversed the inhibitory actions of TSA. This latter cDNA expresses most but not all of the domain in IRF9 required for its interaction with Stat1 and Stat2 (19) .
Chromatin remodeling is well documented to correlate with transcriptionally active genes. Covalent modifications of histones either through acetylation, phosphorylation, or methylation are well described events that alter access of RNA polymerase II and other transcription factors to various promoters.
Acetylation of the histone H3 through recruitment of histone acetylases via Stat1 or Stat2 has been implicated as an important event in IFN␣/␤-stimulated early response genes such as ISG54 (5) . Results presented in this report clearly indicate that HDAC activity is required for IFN␤-mediated expression of ISRE-dependent genes. The inhibitory effects of TSA are not the same on all ISRE-activated genes, and at least the expression of one gene (IRF-1) requiring Stat1 homodimers binding a GAS element is not altered by this HDAC inhibitor. These results partially substantiate those recently reported by Nusinzon and Horvath (20) . However, in contrast to their results, we find that genes in which activation is mediated by a GAS enhancer are not affected by TSA. Our results also provide convincing evidence that inhibition of HDAC activity directly correlates with its potential role in recruiting RNA polymerase II to the endogenous promoters and has no effect on the binding of Stat1 or Stat2 to the ISRE of ISG54 (Fig. 3) . RNA Pol II is associated with the IRF-1 promoter in untreated cells, and its binding is not disrupted by TSA. This observation suggests that RNA Pol II that is already associated with the promoter is independent of the activity of HDACs, whereas recruitment of RNA Pol II to ISRE-containing promoters requires HDAC activity. These results are distinct from those reported by Rascle et al. (8) , where interleukin-3-stimulated Stat5-dependent genes were inhibited by TSA, and the rate of dissociation of RNA Pol II from the promoters of sensitive genes was enhanced when HDACs were inhibited (20) .
In the case of IFN␤-stimulated ISRE-dependent genes, our findings implicate a critical role for IRF9 in mediating the actions of HDACs. Although previous studies have indicated that several IRF family members are acetylated and that acetylation inhibits their ability to bind DNA (21, 22) , our results do not support the notion that treatment of cells with TSA affects the ability of IRF9 to form an ISRE-binding complex with tyrosine-phosphorylated Stat1 and Stat2 (see Fig. 1 ). However, it was not possible to examine whether TSA treatment of cells alters binding of IRF9 to the endogenous ISG54 promoter, because an IRF9 antibody that functions in ChIP assays was not available. We did not observe acetylation of IRF9 either in the presence or absence of incubation of cells with TSA (data not shown). Therefore, the substrate for HDACs that permits RNA Pol II binding to the promoter and the function of IRF9 in this event remain to be determined. We have been unable to detect an interaction between IRF9 and RNA Pol II using immunoprecipitations with either IRF9 or RNA Pol II antisera suggesting, but not proving, that the effects of IRF9 on RNA Pol II recruitment are not direct.
It is notable that expression of only the N-terminal 217 amino acids of IRF9 partially reverses the inhibitory actions of TSA, whereas expression of the first 326 amino acids completely reverses the inhibitory effects of this HDAC inhibitor (Fig. 4C) . Although amino acids 1-326 contain part of the domain required for Stat1 and Stat2 to interact with IRF9, the results of Veals et al. (19) would suggest that this truncated version of IRF9 would not bind tyrosine-phosphorylated Stat1 and Stat2. The fact that incubation of cells with TSA does not inhibit formation of ISGF3, combined with the truncation studies, makes it likely that the domain in IRF9 that is TSAsensitive is distinct from the domain needed to bind Stat1 and Stat2. Studies are in progress to identify the potential targets of TSA that interact with the C terminus of IRF9.
